Pricing Log in Create free account

Jaguar Animal Health, Inc. (JAGX) vs Valion Bio, Inc. (VBIO)

Jaguar Animal Health, Inc. and Valion Bio, Inc. are both Biotechnology companies. Valion Bio, Inc. is the larger, with a market value of $1.1M against $950.0K — 1.1× the size. Jaguar Animal Health, Inc. grew revenue faster over the last twelve months: 135.5% against −49.6%. Valion Bio, Inc. has the higher net margin (0.00% vs −188.5%) and the higher return on invested capital (−61.0% vs −28,393.6%). Across the 18 metrics below, Valion Bio, Inc. leads on 10 and Jaguar Animal Health, Inc. on 8.

Valuation

Metric JAGX VBIO Biotechnology median
P/E n/m n/m 10.60
P/S 0.00 0.14 9.40
P/B 0.00 0.02 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.14 n/m 0.66
EV/Sales (0.12) 11.09 9.02
Earnings yield (1,425,993.60%) (40,026.00%) (32.88%)
Free cash flow yield (34,129.63%) (22,510.36%) (23.13%)

Profitability

Metric JAGX VBIO Biotechnology median
Gross margin 82.31% (58.09%) 68.51%
Operating margin (93.10%) 0.00% 0.00%
Net margin (188.46%) 0.00% 0.00%
Free cash flow margin (24.03%) 0.00% 0.00%
Return on equity (1,125.38%) (489.30%) (51.96%)
Return on assets (127.14%) (104.96%) (46.06%)
Return on invested capital (28,393.64%) (61.01%) 0.00%

Growth

Metric JAGX VBIO Biotechnology median
Revenue growth (TTM) 135.52% (49.63%) 6.76%
EPS growth (last fiscal year) 82.42% 60.16% 29.88%
Revenue growth, 5-year CAGR 4.17% 13.18% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JAGX VBIO Biotechnology median
Debt to equity 0.35 0.62 0.00
Current ratio 0.69 1.11 4.97
Net debt to EBITDA (0.17) 0.79 1.01

Dividend

Metric JAGX VBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric JAGX VBIO Biotechnology median
Market cap 950.00k 1.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack